Table 2 Wald tests of fixed effects based on an adjusted analysis of response profiles of the R/G ratio level.
Variable | DF | Chi-squared | p value |
|---|---|---|---|
R/G baseline | 1 | 3.3 | 0.069 |
POD | 7 | 261.2 | < 0.001 |
Group | 1 | 2.1 | 0.147 |
Group × POD | 7 | 16.2 | 0.023 |
Diabetes | 1 | 10.5 | 0.001 |
CAD | 1 | 15.2 | < 0.001 |
Age (recipient) | 1 | 29.4 | < 0.001 |
Age (donor) | 1 | 6.7 | 0.009 |
Gender (recipient) | 1 | 18.5 | < 0.001 |
Gender (donor) | 1 | 2.0 | 0.158 |
CRP t0 | 1 | 11.9 | < 0.001 |
OTO | 1 | 8.2 | 0.004 |
EVLP | 1 | 0.0 | 0.956 |
ECMO pre | 1 | 5.2 | 0.023 |
ECMO intra | 1 | 29.4 | < 0.001 |
ECMO post | 1 | 0.7 | 0.023 |